2023 Pediatric Tumor Board

Occurs weekly every Wednesday starting on 1/4/2023 at 12:00 PM
Wednesday, January 4, 2023, 12:00 PM - 1:00 PM, 1600 Seventh Avenue South, Lowder Building, Surgical Commons, Birmingham, AL


This series will focus on current treatment practices and controversies in the care of children, adolescents, and young adults with diseases of the blood and cancers. This series will review current literature and background for treatment improving the care of children with the disorders discussed.

1. Describe the current treatment options for the disorder discussed
2. Discuss the diagnostic tools used to make diagnosis.
3. Discuss the epidemiology of the disease process discussed.
4. Apply the information discussed to the care of patients.

Children's of Alabama designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Children’s of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Children's of Alabama adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
3/22/2023 12:00:00 PM	2023 Pediatric Tumor Board 3/22/2023 3/22/2023 12:00:00 PM 3/22/2023 1:00:00 PM 11 1600 Seventh Avenue South, Lowder Building, Surgical Commons False MM/DD/YYYY	2023 Pediatric Tumor Board 3/22/2023 This series will focus on current treatment practices and controversies in the care of children, adolescents, and young adults with diseases of the blood and cancers. This series will review current literature and background for treatment improving the care of children with the disorders discussed. Objective(s): 1 Describe the current treatment options for the disorder discussed 2 Discuss the diagnostic tools used to make diagnosis. 3 Discuss the epidemiology of the disease process discussed. 4 Apply the information discussed to the care of patients. Location: 1600 Seventh Avenue South, Lowder Building, Surgical Commons Specialties: Hematology/Oncology, Pathology, Radiology, General Surgery, RN, CRNP Faculty Disclosures: Elizabeth D Alva, MD (Nothing to disclose - 10/27/2022) Matthew Kutny, MD (Nothing to disclose - 12/06/2022) Download Handout Location: 1600 Seventh Avenue South, Lowder Building, Surgical Commons Specialties: Hematology/Oncology, Pathology, Radiology, General Surgery, RN, CRNP
3/29/2023 12:00:00 PM	2023 Pediatric Tumor Board 3/29/2023 3/29/2023 12:00:00 PM 3/29/2023 1:00:00 PM 11 1600 Seventh Avenue South, Lowder Building, Surgical Commons False MM/DD/YYYY	2023 Pediatric Tumor Board 3/29/2023 This series will focus on current treatment practices and controversies in the care of children, adolescents, and young adults with diseases of the blood and cancers. This series will review current literature and background for treatment improving the care of children with the disorders discussed. Objective(s): 1 Describe the current treatment options for the disorder discussed 2 Discuss the diagnostic tools used to make diagnosis. 3 Discuss the epidemiology of the disease process discussed. 4 Apply the information discussed to the care of patients. Location: 1600 Seventh Avenue South, Lowder Building, Surgical Commons Specialties: Hematology/Oncology, Pathology, Radiology, General Surgery, RN, CRNP Faculty Disclosures: Elizabeth D Alva, MD (Nothing to disclose - 10/27/2022) Matthew Kutny, MD (Nothing to disclose - 12/06/2022) Download Handout Location: 1600 Seventh Avenue South, Lowder Building, Surgical Commons Specialties: Hematology/Oncology, Pathology, Radiology, General Surgery, RN, CRNP

This activity receives no funding from any ineligible companies.